Related Experiment Video
Updated: Mar 10, 2026
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
Published on: December 30, 2025
Practical Concerns and Controversies in the Management of Alcoholic Hepatitis
1Dr Im is an assistant professor of medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai and the Recanati/Miller Transplantation Institute in New York, New York. Dr Lucey is a professor of medicine and chief of the Division of Gastroenterology and Hepatology at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin.
Insights
Glucocorticoids improve short-term survival for alcoholic hepatitis (AH), an aggressive liver disease. This review tackles key controversies in AH diagnosis, prognosis, and management for better patient outcomes.
Area of Science:
- Hepatology
- Internal Medicine
- Clinical Therapeutics
Background:
- Alcoholic hepatitis (AH) is a severe liver disease with high mortality.
- Current treatments, including glucocorticoids, offer limited long-term benefits.
- AH management is complex due to varied presentations and prognoses.
Purpose of the Study:
- To review current controversies and practical issues in alcoholic hepatitis management.
- To provide insights into diagnosis, prognosis, and treatment strategies for AH.
- To inform clinicians on optimizing care for AH patients.
Main Methods:
- Literature review of recent advances in alcoholic hepatitis treatment.
- Analysis of controversies in AH diagnosis and prognosis.
- Discussion of therapeutic approaches and management challenges in AH.
Main Results:
- Glucocorticoids remain a cornerstone for short-term survival in AH.
- Despite advances, AH remains challenging to manage, particularly in younger patients.
- Various prediction models and treatment strategies exist, complicating clinical decisions.
Conclusions:
- Effective management of AH requires addressing key controversies and practical issues.
- Further research is needed to improve long-term outcomes for AH patients.
- A comprehensive approach to diagnosis, prognosis, and treatment is crucial for AH care.
Abstract:
Recent advances in the treatment of alcoholic hepatitis (AH) have reinforced the utility of glucocorticoids, a treatment that has been in use for nearly 4 decades, to enhance short-term survival. As multi-institutional consortia research new therapeutic advances, this orphan disease, which afflicts younger patients and has poor outcomes, continues to be difficult to manage. AH has a protean clinical presentation and course, with various prediction models and treatment approaches that can challenge even experienced providers. This review addresses 4 key controversies and other practical issues associated with the diagnosis, prognosis, management, and treatment of patients with AH.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:22Myocarditis IV: Nursing Management
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...